As of March 2025 GlaxoSmithKline has a market cap of A$127.29 Billion. This makes GlaxoSmithKline the world's 237th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$127.29 B | 13.87% |
2024 | A$111.78 B | -0.12% |
2023 | A$111.92 B | 5.88% |
2022 | A$105.70 B | -29.76% |
2021 | A$150.49 B | 26.11% |
2020 | A$119.34 B | -28.21% |
2019 | A$166.23 B | 24.66% |
2018 | A$133.34 B | 18.14% |
2017 | A$112.87 B | -13.65% |
2016 | A$130.71 B | -3.87% |
2015 | A$135.97 B | 6.83% |
2014 | A$127.28 B | -12% |
2013 | A$144.63 B | 42.11% |
2012 | A$101.77 B | -9.41% |
2011 | A$112.34 B | 11.99% |
2010 | A$100.31 B | -17.82% |
2009 | A$122.07 B | -10.9% |
2008 | A$137.00 B | -13.69% |
2007 | A$158.74 B | -17.59% |
2006 | A$192.61 B | -4.36% |
2005 | A$201.40 B | 10.78% |
2004 | A$181.80 B | 2.62% |
2003 | A$177.16 B | -11.54% |
2002 | A$200.27 B | -33.53% |
2001 | A$301.30 B | -4.37% |
2000 | A$315.07 B | 103.55% |
1999 | A$154.78 B | -24.78% |
1998 | A$205.77 B | 56.66% |
1997 | A$131.34 B | 85.38% |
1996 | A$70.85 B |
On Mar 22nd, 2025 the market cap of GlaxoSmithKline was reported to be: